Katherine Ory

Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

Katherine Ory, Yann Legros, C. Auguin et al. · The EMBO Journal · 1994 · 230 citations · Full text

Tumor Biology, Medicine, Cancer Growth +8

Gene Expression Profiling of Differentiated Thyroid Neoplasms

Sylvie Chevillard, Nicolas Ugolin, Philippe Vielh et al. · Clinical Cancer Research · 2004 · 122 citations · Full text

Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines

Katherine Ory, J. Lebeau, Céline Levalois et al. · Breast Cancer Research and Treatment · 2001 · 41 citations

Medroxyprogesterone Acetate Treatment, Breast Oncology, Oncology +10

Progesterone prevents radiation-induced apoptosis in breast cancer cells

Guillaume Varès, Katherine Ory, Bruno Lectard et al. · Oncogene · 2004 · 31 citations

Breast Oncology, Radiation-induced Apoptosis, Apoptosis +5

Down-regulation of telomerase activity after progesterone treatment of human breast cancer cells: essential role of the cell cycle status.

J. Lebeau, Pierre Fouchet, Katherine Ory et al. · PubMed · 2002 · 14 citations

Breast Oncology, Telomerase Activity, Cell Cycle Blockage +16